Skip to content
ClinCalc Pro
Menu
Stimulant Laxative / Bowel Preparation Agent

Sodium Picosulfate

Brand names: Dulcolax Pico, Laxoberal, Picolax (with magnesium citrate)

Sodium picosulfate is a stimulant laxative used for constipation and, in higher-strength combination products, for bowel cleansing before colonoscopy or surgery.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is hydrolysed by colonic bacteria into an active form that stimulates the mucosa of the large bowel, increasing motility and water secretion.

Prescribing in practice

  • Bowel-cleansing preparations carry a risk of fluid and electrolyte disturbance and dehydration, so maintain adequate hydration and use with caution in frail, elderly, or renally impaired patients.
  • It is contraindicated in intestinal obstruction, ileus, severe inflammatory bowel disease, and toxic megacolon.
  • Effect is typically seen within several hours, so timing of administration should account for the expected onset.

Monitoring

Monitor for signs of dehydration and electrolyte imbalance, particularly with bowel-cleansing regimens in at-risk patients.

Counselling the patient

  • Drink plenty of clear fluids during bowel preparation to avoid dehydration.
  • Expect loose, watery stools and stay near a toilet once the dose takes effect.

Evidence & guidelines

Stimulant laxatives such as sodium picosulfate are established agents for constipation and bowel preparation in UK practice.

Reference: BSG Bowel Preparation Guidelines; SPC Picolax; SPC Laxoberal; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.